CNSY:NASDAQ
Cerenome, Inc.
$2.17
arrow_downward
-6.67%(-0.15) 1D
$2.19
arrow_upward
+0.80% (+0.017)bedtimeAfter hours
Closed: Sep 14, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CNSY...
Open
$2.30
High
$2.32
Low
$2.17
Mkt. cap
16.43M
Avg. vol.
74.15K
Volume
155.61K
52-wk high
$4.16
52-wk low
$2.17
EPS
-$4.42
Beta
1.39
Shares outstanding
7.59M
No. of employees
28
Open
$2.30
High
$2.32
Low
$2.17
Mkt. cap
16.43M
Avg. vol.
74.15K
Volume
155.61K
52-wk high
$4.16
52-wk low
$2.17
EPS
-$4.42
Beta
1.39
Shares outstanding
7.59M
No. of employees
28
Profile
Cerenome, Inc. is a clinical-stage pharmaceutical company headquartered in Houston, Texas, that develops targeted radiotherapeutics and diagnostic services for brain and central nervous system cancers. The company’s lead therapeutic candidate, marketed as REYOBIQ™, is an investigational liposomal radiopharmaceutical under clinical evaluation for recurrent glioblastoma, leptomeningeal metastases, and certain pediatric brain cancers. Cerenome also commercialized a molecular diagnostic service, CNSide®. Wikipedia
About Cerenome, Inc.